$5.14+0.07 (+1.38%)
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.
AUNA in the Healthcare sector is trading at $5.14. The stock is currently 29% below its 52-week high of $7.20, remaining 7.9% below its 200-day moving average. Technical signals show neutral RSI of 30 and bearish MACD signal, explaining why AUNA maintains its current current market pressure. The Whystock Score of 35/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans; and dental and vision insurance plans. It also sells medicines. The company was founded in 1989 and...
Auna S.A. (AUNA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AUNA eyes 12% EBITDA growth by 2026 as Mexico stabilizes, refinancing cuts costs, and hospital network gains boost demand across key markets.
Medpace (MEDP) delivered earnings and revenue surprises of +14.54% and +1.78%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Auna S.A. gains from Peru growth, stabilizing Mexico and Colombia cash flow focus, while Surgery Partners faces earnings cuts and headwinds.
Auna’s refreshed analyst narrative keeps the fair value target steady at $7.20 per share, even as inputs around discount rates and valuation assumptions are fine tuned. Bullish and bearish analysts both anchor their views to this $7.20 level as they debate how well Auna can execute against its plans to justify holding that line. As you read on, you will see how to track this evolving story and what to watch as new information comes through. Stay updated as the Fair Value for Auna shifts by...